Immunity Enhancement in Immunocompromised Gastrointestinal Cancer Patients with Allogeneic Umbilical Cord Blood Mononuclear Cell Transfusion

BioMed Research International
Ying QiuSheng Yun

Abstract

Objectives . In order to enhance the immunity of cancer patients to prevent relapse or to prolong survival time, umbilical cord blood mononuclear cells (UCMCs) were transplanted to cancer patients.Patients and Methods. UCMCs were transfused to 63 immunocompromised gastrointestinal cancer patients with nonmyeloablative (NMA) conditioning regimen.Results. The clinical study showed that the number of both T and B cells increased much more rapidly after transfusion of UCMCs than that of the control group without transplantation (p< 0.01). Proinflammation cytokines IFNγand TNFαin serum increased to or above the normal range in 80.9% of patients at 12 weeks after UCMC transfusion. However, they recovered to the normal range in 21.7% of patients at the same time point in the control group only. In addition, the clinical investigation also showed that the transfusion of UCMC increased stable disease (SD) and reduced progressive disease (PD) significantly (p< 0.01); however, it did not have significant effects on complete response (CR), partial response (PR), or mortality rates compared with the control group (p> 0.05).Conclusions. UCMCs have powerful repairing effects on damaged cells and tissues and may reconstruct the impaired immuni...Continue Reading

References

Aug 26, 1999·Respiration; International Review of Thoracic Diseases·J CadranelC Mayaud
Jan 29, 2008·Current Stem Cell Research & Therapy·David T Harris, Ian Rogers
Jul 22, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sandeep ChunduriDamiano Rondelli
Aug 28, 2009·Journal of Cellular Biochemistry·Anja BuchheiserGesine Kögler
Mar 17, 2010·Journal of Reproductive Immunology·Anastasios E Germenis, Vaios Karanikas
May 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Remko SchotteBianca Blom
Oct 12, 2010·Biomedical and Environmental Sciences : BES·Ling WangJie Li
Nov 15, 2011·Oral Oncology·Shailesh M GondivkarSwati Balsaraf
Dec 20, 2011·Current Bioactive Compounds·Chikako OgawaKoichi S Kobayashi
Jan 13, 2012·Annals of the New York Academy of Sciences·Noel Fcc de MirandaQiang Pan-Hammarström
Apr 3, 2012·Seminars in Cancer Biology·Theresa L Whiteside
Apr 17, 2012·Immunological Reviews·Jason S WeinsteinJoe Craft
Apr 2, 2013·Seminars in Diagnostic Pathology·Adam Bagg, Cherie H Dunphy
Nov 19, 2013·Journal of Clinical Immunology·Beatriz Tavares Costa-CarvalhoAntonio Condino-Neto
Nov 7, 2014·Cytotechnology·Anna HordyjewskaAnna Horecka
Jun 1, 2015·Environmental Toxicology and Pharmacology·Kobra ShiraniGholamreza Karimi
Jul 15, 2015·Frontiers in Physiology·Ebtehaj ManetaRaheela N Khan
Feb 21, 2016·Current Opinion in Biotechnology·Sandeep T Koshy, David J Mooney
Mar 17, 2016·Cytokine & Growth Factor Reviews·Jens GeginatRichard A Flavell

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
flow
ELISA
flow cytometry
FACS

Software Mentioned

BD FACSDiva

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.